Accessibility Tools
Skip to main content
Perfil investigador
Esp
Dr. Perla Yolanda López Camacho

Professor
Departament of Natural Sciences

Division of Natural Sciences and Engineering


Level 1
Member of the National System of Researchers
(SNII)

Biology and chemistry



Cuajimalpa Campus

Return to list
New search




Sustainable Development Goals

• 3 Good Health and Well-being

• 4 Quality Education

• 12 Responsible Consumption and Production


Research interests

• Pharmacological evaluation of molecules
• Molecular synthesis
• Molecular design

Profile

Professor Perla López is a Pharmacobiological Chemist graduated from the Universidad Michoacana de San Nicolás de Hidalgo. She has a Master's degree and a Ph.D. in Sciences with a specialty in Pharmacobiology, both from the Centro de Investigación y de Estudios Avanzados from the Instituto Politécnico Nacional.

She is currently a professor attached to the Department of Natural Sciences at the Universidad Autónoma Metropolitana, Cuajimalpa Campus. She has the Recognition of Desirable Profile, granted by the Ministry of Public Education.

Her research is related to obtaining molecules from natural products and chemical synthesis, their identification, and chemical characterization, as well as the in vitro and in vivo evaluation of the pharmacological activity of diverse molecules. She has participated in tutorial committees of graduate students and directed research projects at the undergraduate level. She has led research projects and book chapters.

In the educational field, she participates as a professor in the undergraduate program in Molecular Biology and the graduate program in Natural Sciences and Engineering at UAM Cuajimalpa Campus.



Information provided by the academic staff

Research interests

• Pharmacological evaluation of molecules
• Molecular synthesis
• Molecular design

Academic Work

On the following pages you can consult the research work:



Other sites of interest

Consult the research work on other websites:






Some examples of publications

Select the bibliographic reference to consult each publication:


Open Access References UN SDGs
Zavala-Ocampo, L.M., Mendoza-Franco, G., Aparicio-Bautista, D.I. and 3 more (...) (2026).Petiveria alliacea L. methanolic extract inhibits amyloid-β aggregation and enhances cell viability in SH-SY5Y cells: in vitro and in silico evidence. Journal of Ethnopharmacology,362
OACastillo-Villanueva, C.J., Anacleto-Santos, J., López-Pérez, T.J. and 8 more (...) (2026).Inhibitors of the FASII Metabolic Pathway in Toxoplasma gondii: Advances and Therapeutic Perspectives. Microorganisms,14(5)
OAAnacleto-Santos, J., Mondragón-Flores, R., López-Camacho, P.Y. and 8 more (...) (2025).Anti-Toxoplasma and Antioxidant Activity of a Terpene and Methyl-Ester-Rich Subfraction from Pleopeltis crassinervata. Antioxidants,14(3)
OABasurto-Islas, G., Diaz, M.C., Ocampo, L.M.Z. and 2 more (...) (2025).Natural products against tau hyperphosphorylation-induced aggregates: Potential therapies for Alzheimer's disease. Archiv der Pharmazie,358(1)
Zavala-Ocampo, L.M., López-Camacho, P.Y., Aguirre-Hernández, E. and 3 more (...) (2024).Neuroprotective effects of Petiveria alliacea on scopolamine-induced learning and memory impairment mouse model. Journal of Ethnopharmacology,318
Cruz-Hernández, C., López-Camacho, P.Y., Basurto-Islas, G. and 3 more (...) (2024).Click synthesis of dendronized malonates for the preparation of amphiphilic dendro[60]fullerenes. Organic and Biomolecular Chemistry,22(16) 3328-3339
OAAnacleto-Santos, J., Vega-Ávila, E., Pacheco, L. and 8 more (...) (2024).Antibacterial, Trichomonacidal, and Cytotoxic Activities of Pleopeltis crassinervata Extracts. Pharmaceutics,16(5)
OAAnacleto-Santos, J., Calzada, F., López-Camacho, P.Y. and 7 more (...) (2023).Evaluation of the Anti-Toxoplasma gondii Efficacy, Cytotoxicity, and GC/MS Profile of Pleopeltis crassinervata Active Subfractions. Antibiotics,12(5)
Martińez-Herrera, M., Figueroa-Gerstenmaier, S., López-Camacho, P.Y. and 6 more (...) (2022).Multiadducts of C60Modulate Amyloid-β Fibrillation with Dual Acetylcholinesterase Inhibition and Antioxidant Properties: In Vitro and in Silico Studies. Journal of Alzheimer's Disease,87(2) 741-759
Zavala-Ocampo, L.M., Aguirre-Hernández, E., López-Camacho, P.Y. and 3 more (...) (2022).Acetylcholinesterase inhibition and antioxidant activity properties of Petiveria alliacea L.. Journal of Ethnopharmacology,292
Anacleto-Santos, J., López-Camacho, P.Y., Vega-ávila, E. and 3 more (...) (2021).Anti-Toxoplasma Drug Discovery and Natural Products: a Brief Overview. Frontiers in Clinical Drug Research - Anti Infectives,7103-126
Maldonado-Moreles, A., Cordova-Fraga, T., Bonilla-Jaime, H. and 2 more (...) (2021).Low frequency vortex magnetic field reduces amyloid β aggregation, increase cell viability and protect from amyloid β toxicity. Electromagnetic Biology and Medicine,40(1) 191-2003
OALópez-Camacho, P.Y., Martínez-Espinosa, J.C., Basurto-Islas, G. and 4 more (...) (2021).Spondias mombin seed oil compounds identification by raman spectroscopy and NMR. Applied Sciences (Switzerland),11(6) 3
OATorres-Moreno, A.Y., Belío-Reyes, I.A., García-Medina, S. and 4 more (...) (2021).Behaviour of nanocrystalline tricalcium silicate-based cements at early stages of hydration. Materials Research Express,8(3)
OAAnacleto-Santos, J., López-Camacho, P., Mondragón-Flores, R. and 5 more (...) (2020).Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fraction. Saudi Journal of Biological Sciences,27(3) 812-819

© 2026 Elsevier B.V. All rights reserved. SciVal, RELX Group and the RE symbol are trade marks of RELX Intellectual Properties SA, used under license.

Courses taught by the professor in recent trimesters

*Courses are conducted in spanish

Num.Trim.Course NameLevel
1
26P
Proyecto de Investigación IPosgrado
2
26P
Seminario IIPosgrado
3
26P
Introducción a la FarmacologíaLicenciatura
4
26P
Equilibrio y Cinética QuímicaLicenciatura
5
26I
QuímicaLicenciatura
6
26I
Farmacología MolecularLicenciatura
7
25O
Trabajo de Especialidad IIIPosgrado
8
25O
Introducción a la FarmacologíaLicenciatura
9
25O
Introducción a la FarmacologíaLicenciatura
10
25O
Proyecto Terminal IILicenciatura
11
25O
Proyecto Terminal IIILicenciatura
12
25P
Trabajo de Especialidad IIPosgrado
13
25P
Proyecto Terminal IILicenciatura
14
25P
Química IILicenciatura
15
25P
Seminario IIIPosgrado
16
25I
Equilibrio y Cinética QuímicaLicenciatura
17
25I
Trabajo de Especialidad IPosgrado
18
25I
Farmacología MolecularLicenciatura
19
25I
Proyecto de Investigación IIIPosgrado
20
25I
Proyecto Terminal ILicenciatura
21
25I
Seminario de EspecialidadPosgrado
22
24O
Introducción a la FarmacologíaLicenciatura
23
24O
Proyecto de Investigación IIPosgrado
24
24O
Seminario IIPosgrado
25
24P
Temas Selectos IIPosgrado
26
24P
Proyecto de Investigación IPosgrado
27
24P
Proyecto Terminal ILicenciatura
28
24I
Equilibrio y Cinética QuímicaLicenciatura
29
24I
Farmacología MolecularLicenciatura
30
24I
Proyecto Terminal IILicenciatura
31
24I
Seminario IPosgrado
32
23O
Proyecto Terminal ILicenciatura
33
23O
Introducción a la FarmacologíaLicenciatura
34
23O
Introducción a la FarmacologíaLicenciatura
35
23P
Química IILicenciatura
36
23I
Farmacología MolecularLicenciatura
37
23I
Equilibrio y Cinética QuímicaLicenciatura
38
22O
Introducción a la FarmacologíaLicenciatura
39
22O
Introducción a la FarmacologíaLicenciatura
40
22O
Trabajo de Redacción de Tesis IIIPosgrado
41
22P
Trabajo de Redacción de Tesis IIPosgrado
42
22I
Equilibrio y Cinética QuímicaLicenciatura
43
22I
Farmacología MolecularLicenciatura
44
22I
Proyecto Terminal IILicenciatura
45
22I
Proyecto Terminal IILicenciatura
46
22I
Proyecto Terminal IIILicenciatura
47
22I
Trabajo de Redacción de Tesis IPosgrado
Information provided by the Dirección de Sistemas Escolares
Return to list
New search





Universidad Autónoma Metropolitana, 2026.